Knight Therapeutics buy krebskrebs
Start price
30.11.20
/
50%
€3.50
Target price
30.11.21
€4.00
Performance (%)
5.14%
End price
01.12.21
€3.68
Summary
This prediction ended on 01.12.21 with a price of €3.68. The BUY prediction by krebskrebs finished with a performance of 5.14%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Knight Therapeutics | 2.747% | 2.747% | 23.026% | 3.315% |
iShares Core DAX® | -1.414% | 7.218% | 17.151% | 15.732% |
iShares Nasdaq 100 | -2.316% | 4.450% | 18.360% | 30.945% |
iShares Nikkei 225® | -2.756% | 10.071% | 10.704% | 2.733% |
iShares S&P 500 | -1.849% | 4.760% | 19.639% | 34.852% |
Comments by krebskrebs for this prediction
In the thread Knight Therapeutics diskutieren
Buy mit Kursziel 4,0
In the thread Trading Knight Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten